Residency · Residency · Child Adolescent Psychiatry

Psychiatric Aspects of Pediatric Chronic Illness

Introduction

Approximately 25-30% of children in the United States live with a chronic medical condition, and these children are at significantly elevated risk for psychiatric comorbidity. Pediatric consultation-liaison psychiatry addresses the complex interface between physical illness and mental health, recognizing that psychological well-being directly affects disease management, treatment adherence, and medical outcomes.

Epidemiology

Children with chronic illness have two to three times the risk of psychiatric disorders compared to healthy peers. Depression and anxiety are the most common comorbidities across conditions. Rates of psychiatric comorbidity are highest in conditions affecting the central nervous system, such as epilepsy and brain tumors, and in conditions requiring complex self-management, such as diabetes and cystic fibrosis. Approximately 20-30% of chronically ill children meet criteria for a psychiatric diagnosis. Psychiatric comorbidity is associated with poorer medical outcomes, higher healthcare costs, and reduced quality of life.

Psychological Impact of Chronic Illness by Developmental Stage

Infancy and Early Childhood (0-5 years)

In the earliest years, chronic illness disrupts attachment through hospitalizations and painful procedures. Developmental delays may occur secondary to illness and treatment. Caregiver distress profoundly impacts the parent-child relationship.

School Age (6-12 years)

School-age children face disruption of peer relationships and school attendance. Feelings of being different from peers emerge. As cognitive development progresses, children develop an emerging understanding of their illness and its implications. Academic difficulties may result from school absence, fatigue, or cognitive effects of treatment.

Adolescence (13-18 years)

Chronic illness threatens autonomy and identity formation during adolescence. Non-adherence may emerge as an expression of the developmental need for independence. Body image concerns are amplified by disease or treatment effects. Risk-taking behaviors may exacerbate medical conditions. Transition planning to adult medical care becomes a significant concern.

Psychiatric Comorbidity in Specific Conditions

Summary of Psychiatric Comorbidity by Chronic Illness

Type 1 Diabetes

Depression is present in 15-25% of youth with type 1 diabetes and significantly worsens glycemic control. Diabetes distress, which is distinct from clinical depression and characterized by frustration with disease management, is common. Eating disorders may manifest as insulin omission for weight loss, sometimes called "diabulimia." Anxiety about hypoglycemia is frequently reported.

Epilepsy

Depression and anxiety occur in 30-50% of pediatric epilepsy patients. The relationship between seizures and mood is bidirectional. ADHD is highly prevalent, and stimulants are generally safe to use. The FDA black box warning regarding suicidality with antiepileptic drugs warrants awareness, though the absolute risk is low.

Asthma

Anxiety disorders are common in children with asthma and may amplify symptom perception. Panic disorder can be confused with asthma exacerbation, complicating diagnosis. Depression is associated with reduced adherence and increased emergency room visits.

Cancer

Acute adjustment disorders are common during treatment. PTSD develops in up to 20% of survivors and their parents. Neurocognitive late effects from CNS-directed treatment, including radiation and intrathecal chemotherapy, can persist long after remission. Survivorship issues include fear of recurrence, identity concerns, and fertility worries.

Inflammatory Bowel Disease

Depression and anxiety affect 25-35% of youth with inflammatory bowel disease. Social isolation related to symptoms such as urgency and incontinence is common. Corticosteroid-induced psychiatric effects, including mania, psychosis, and depression, may complicate the clinical picture.

Assessment Framework

Validated, disease-specific screening tools should be used when available, including the PHQ-A for depression and PROMIS measures for broader assessment. Coping style should be assessed, distinguishing between active and avoidant strategies. Treatment adherence and barriers to adherence should be evaluated. Caregiver mental health should be screened, as parental depression and PTSD are common and directly affect child outcomes. Pain, fatigue, and sleep should be assessed as contributors to psychiatric symptoms. Iatrogenic psychiatric effects of medications, including corticosteroids, interferons, and immunosuppressants, should be considered.

Treatment Approaches

Psychotherapy

CBT adapted for chronic illness targets illness-related cognitions, behavioral activation, and coping skills. Acceptance and commitment therapy promotes psychological flexibility in the context of ongoing illness. Family therapy addresses illness-related communication, roles, and boundaries. Supportive therapy and psychoeducation provide ongoing guidance.

Pharmacotherapy

SSRIs are first-line for depression and anxiety in medically ill youth. Drug-drug interactions must be carefully evaluated; for example, fluoxetine inhibits CYP2D6. Medications that could worsen the medical condition, such as bupropion in epilepsy, should be avoided. Pharmacokinetic changes due to hepatic or renal impairment must be considered. Low starting doses with careful titration are appropriate.

Integrated Care Models

Collaborative care models embed mental health services within pediatric specialty clinics. Psychologists and psychiatrists function as part of the multidisciplinary medical team. Routine mental health screening in chronic disease clinics improves detection. Shared electronic health records and treatment planning enhance coordination.

Procedural Support

Preparation and coping interventions for medical procedures reduce distress and improve cooperation. Distraction techniques, guided imagery, and hypnosis are effective for needle phobia and procedural anxiety. Identification and treatment of medical traumatic stress is an important but often overlooked component of care.

Clinical Pearls

Depression in chronically ill children is underdiagnosed and undertreated; routine screening should be integrated into medical care. Non-adherence is often a psychiatric issue, and clinicians should always assess for depression, family conflict, and cognitive barriers before assuming willful non-compliance. Corticosteroids are a common cause of iatrogenic psychiatric symptoms, and any child on chronic steroids should be screened for mood changes, psychosis, and sleep disturbance. Psychiatric care that is siloed from medical care produces suboptimal outcomes for both; treating the whole patient requires integrated approaches.

References

1. Pao M, Bosk A. "Anxiety in Medically Ill Children/Adolescents." Depression and Anxiety. 2011;28(1):40-49.
2. Compas BE, et al. "Coping with Chronic Illness in Childhood and Adolescence." Annual Review of Clinical Psychology. 2012;8:455-480.
3. Pinquart M, Shen Y. "Depressive Symptoms in Children and Adolescents with Chronic Physical Illness: An Updated Meta-Analysis." JCPP. 2011;52(8):906-912.
4. DeMaso DR, et al. "Practice Parameter for the Psychiatric Assessment and Management of Physically Ill Children and Adolescents." JAACAP. 2009;48(2):213-233.

Read this lecture as Markdown